Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 15/20 | 0.82 |
| ▸ | SRD5A2 | P31213 | 8/20 | 0.82 |
| ▸ | LMNA | P02545 | 2/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.82 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.82 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.82 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.82 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.82 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.82 |
| ▸ | HSD3B1 | P14060 | 1/20 | 0.82 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.82 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.82 |
| ▸ | THPO | P40225 | 1/20 | 0.82 |
| ▸ | BLM | P54132 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9134496 | 1.00 | SRD5A1 (0.82) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL8749711 | 0.93 | SRD5A1 (0.82) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL2297747 | 0.93 | SRD5A1 (0.82) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL2294804 | 0.92 | SRD5A1 (0.81) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL8793134 | 0.92 | SRD5A1 (0.81) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL8793136 | 0.92 | SRD5A1 (0.81) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL2294809 | 0.92 | SRD5A1 (0.81) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL2293254 | 0.91 | SRD5A1 (0.80) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL2293256 | 0.91 | SRD5A1 (0.80) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL4173615 | 0.91 | SRD5A1 (0.80) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0271220-B1 | OXIDIZED ANALOGS OF 17 BETA-N-MONOSUBSTITUTED CARBAMOYL-4-AZA 5 ALPHA-ANDROST-1-EN-3-ONES | MERCK & CO. INC. (US) | 1992-01-29 | — | — | EP | claimed |
| US-4845104-A | Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones | MERCK & CO., INC. (US) | 1989-07-04 | — | — | US | claimed |
| EP-0271220-A1 | Oxidized analogs of 17 beta-N-monosubstituted carbamoyl-4-aza 5 alpha-androst-1-en-3-ones | MERCK & CO. INC. (US) | 1988-06-15 | — | — | EP | claimed |
| EP-0271220-B1 | OXIDIZED ANALOGS OF 17 BETA-N-MONOSUBSTITUTED CARBAMOYL-4-AZA 5 ALPHA-ANDROST-1-EN-3-ONES | MERCK & CO. INC. (US) | 1992-01-29 | — | — | EP | disclosed |
| US-4845104-A | Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones | MERCK & CO., INC. (US) | 1989-07-04 | — | — | US | disclosed |
| EP-0271220-A1 | Oxidized analogs of 17 beta-N-monosubstituted carbamoyl-4-aza 5 alpha-androst-1-en-3-ones | MERCK & CO. INC. (US) | 1988-06-15 | — | — | EP | disclosed |